Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Jong Yun, PhD

Jong Yun, PhD

Associate Professor, Department of Pharmacology
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Scientific Program:Next-Generation Therapies
JKY1@psu.edu

Recent Publications

2024

Hengst, JA, Nduwumwami, AJ, Sharma, A & Yun, JK 2024, 'Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?', Molecular pharmacology, vol. 105, no. 3, pp. 155-165. https://doi.org/10.1124/molpharm.123.000786

2023

Kale, VP, Hengst, JA, Sharma, AK, Golla, U, Dovat, S, Amin, SG, Yun, JK & Desai, DH 2023, 'Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases', Pharmaceuticals, vol. 16, no. 8, 1060. https://doi.org/10.3390/ph16081060

2022

Hengst, JA, Nduwumwami, AJ, Raup-Konsavage, WM, Vrana, KE & Yun, JK 2022, 'Inhibition of Sphingosine Kinase Activity Enhances Immunogenic Cell Surface Exposure of Calreticulin Induced by the Synthetic Cannabinoid 5-epi-CP-55,940', Cannabis and Cannabinoid Research, vol. 7, no. 5, pp. 637-647. https://doi.org/10.1089/can.2021.0100
Hengst, JA, Nduwumwami, AJ & Yun, JK 2022, 'Regulatory Role of Sphingosine-1-Phosphate and C16:0 Ceramide, in Immunogenic Cell Death of Colon Cancer Cells Induced by Bak/Bax-Activation', Cancers, vol. 14, no. 21, 5182. https://doi.org/10.3390/cancers14215182

2021

Nduwumwami, AJ, Hengst, JA & Yun, JK 2021, 'Sphingosine kinase inhibition enhances dimerization of calreticulin at the cell surface in mitoxantrone-induced immunogenic cell death', Journal of Pharmacology and Experimental Therapeutics, vol. 378, no. 3, pp. 300-310. https://doi.org/10.1124/jpet.121.000629

2020

Hengst, JA, Dick, TE, Smith, CD & Yun, JK 2020, 'Analysis of selective target engagement by small-molecule sphingosine kinase inhibitors using the Cellular Thermal Shift Assay (CETSA)', Cancer Biology and Therapy, vol. 21, no. 9, pp. 841-852. https://doi.org/10.1080/15384047.2020.1798696
Hengst, JA, Hegde, S, Paulson, RF & Yun, JK 2020, 'Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization', Bioorganic and Medicinal Chemistry Letters, vol. 30, no. 20, 127453. https://doi.org/10.1016/j.bmcl.2020.127453